danlb_2000
Premium Member
I'll be somewhat of the good cop here, at least on why the vaccines came out so quickly.
There were no skipped safety steps in the development of these vaccines. The reasons for the quick development:
1) The specific technique using mRNA has already been in development for over a decade. This technique allows for very rapid early development of new vaccines because all you need to know is the complete structure of the specific viral protein the vaccine is meant to target, and with modern lab techniques that didn't exist until the last few decades (like polymerase chain reactors), you can sequence an entire protein or genome in a matter of hours, whereas before it may have taken months or even years.
2) The urgency of finding a vaccine for a disease that has now become the 3rd leading cause of death in the world meant that governments were willing to guarantee the purchase of the vaccines even before they were approved. This guaranteed financing meant that drug companies could skip several lengthy administrative steps in the vaccine development process that would traditionally be spent soliciting investor capital.
3) The very fact that the pandemic was raging out of control allowed the researches to rapidly accumulate enough cases in the control group to reach statistical significance for the vaccine effect in the treatment group. For diseases that have thousands of cases per year, it can take up to a decade to reach statistical significance, but for this pandemic, worldwide, we can count the cases accumulating in the 100,000s EVERY SINGLE DAY.
Right now, these vaccines have been more widely tested and monitored than any previous inoculuation in history. The safety and efficacy data are overwhelming convincing. We are approaching two months out since the Pfizer vaccine was approved, and of the most concerning side-effect typically associated with vaccines, Guillain-Barre syndrome, we HAVE NOT SEEN A SINGLE CASE. the worst we have seen are anaphylactic reactions, a severe but easily treatable condition, but at an even lower rate than typical for other vaccines.
You really need to reconsider your sources of information.
They also did a lot of things in parallel instead of doing it step by step like they would normally do. So, for example, they started ramping up the manufacturing operations before the trials were even complete. This is not something that would normally happen since it it financially risky. If a problem was found during trials, they could end up having to discard everything they had already made.